Back
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.8 No.2, February 16, 2017  DOI: 10.4236/jct.2017.82015
       (PDF  452K)     HTML      XML
Nimotuzumab in Management of Brain Stem Glioma: A Case Report
K. S. Kirushna Kumar, P. Ananda Selvakumar, Krishna Kumar Rathinam
J. Cancer Ther. Vol.8 No.2, February 24, 2017  DOI: 10.4236/jct.2017.82018
       (PDF  728K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek
J. Cancer Ther. Vol.6 No.4, April 13, 2015  DOI: 10.4236/jct.2015.64036
       (PDF  473K)     HTML      XML
A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents
Stanislaw R. Burzynski, Gregory S. Burzynski, Sheldon Brookman
J. Cancer Ther. Vol.6 No.1, January 08, 2015  DOI: 10.4236/jct.2015.61006
       (PDF  2621K)     HTML      XML
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Recurrent, Refractory or Progressive Primary Brain Tumors—Final Report (Protocol BT-22)
Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski, Ania Marszalek, Sheldon Brookman
J. Cancer Ther. Vol.5 No.10, September 10, 2014  DOI: 10.4236/jct.2014.510102
       (PDF  2670K)     HTML     
 
 
Top